Solara Active Pharma Sciences Limited (SOLARA.BO)
INR 489.25
(-4.81%)
INR 489.25
(-4.81%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -3.85 Billion INR | -3853.74% |
| 2022 | 85.6 Million INR | 125.72% |
| 2021 | -332.8 Million INR | -112.71% |
| 2020 | 2.61 Billion INR | 53.49% |
| 2019 | 1.7 Billion INR | 13.15% |
| 2018 | 1.5 Billion INR | 420.11% |
| 2017 | 289.84 Million INR | 878403.03% |
| 2016 | -33 Thousand INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 168.5 Million INR | 112.18% |
| 2024 Q2 | 359.7 Million INR | 113.47% |
| 2023 Q4 | -1.38 Billion INR | 26.12% |
| 2023 Q1 | -67.9 Million INR | -130.42% |
| 2023 Q2 | 114.2 Million INR | 268.19% |
| 2023 FY | -3.21 Billion INR | -3853.74% |
| 2023 Q3 | -1.87 Billion INR | -1739.23% |
| 2022 Q2 | -10.6 Million INR | 93.2% |
| 2022 Q4 | 223.2 Million INR | 31.14% |
| 2022 FY | 85.6 Million INR | 125.72% |
| 2022 Q1 | -155.8 Million INR | -9.03% |
| 2022 Q3 | 170.2 Million INR | 1705.66% |
| 2021 Q4 | -142.9 Million INR | 88.59% |
| 2021 FY | -332.8 Million INR | -112.71% |
| 2021 Q3 | -1.25 Billion INR | -388.13% |
| 2021 Q2 | 434.8 Million INR | -31.79% |
| 2021 Q1 | 637.4 Million INR | -11.06% |
| 2020 FY | 2.61 Billion INR | 53.49% |
| 2020 Q2 | 761.4 Million INR | 22.51% |
| 2020 Q1 | 621.5 Million INR | 121.65% |
| 2020 Q3 | 862.4 Million INR | 13.27% |
| 2020 Q4 | 716.7 Million INR | -16.89% |
| 2019 Q4 | 280.4 Million INR | -53.19% |
| 2019 FY | 1.7 Billion INR | 13.15% |
| 2019 Q3 | 599 Million INR | 21.08% |
| 2019 Q2 | 494.7 Million INR | 9.57% |
| 2019 Q1 | 451.5 Million INR | 17.13% |
| 2018 Q4 | 385.46 Million INR | -13.65% |
| 2018 FY | 1.5 Billion INR | 420.11% |
| 2018 Q1 | 274.7 Million INR | 8.15% |
| 2018 Q2 | 301.2 Million INR | 9.65% |
| 2018 Q3 | 446.4 Million INR | 48.21% |
| 2017 Q4 | 254 Million INR | 0.0% |
| 2017 Q2 | 63.62 Million INR | -71.81% |
| 2017 Q1 | 225.7 Million INR | 0.0% |
| 2017 FY | 289.84 Million INR | 878403.03% |
| 2016 FY | -33 Thousand INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bal Pharma Limited | 233.9 Million INR | 1747.179% |
| Achyut Healthcare Limited | 4.43 Million INR | 86916.133% |
| Alkem Laboratories Limited | 19.46 Billion INR | 119.797% |
| Divi's Laboratories Limited | 33.08 Billion INR | 111.647% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 159.254% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 142.909% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | -2435.52% |
| Mankind Pharma Limited | 21.51 Billion INR | 117.905% |
| Medicamen Biotech Limited | - INR | Infinity% |
| Medico Remedies Limited | 100.3 Million INR | 3941.376% |
| Megasoft Limited | -121.1 Million INR | -3081.48% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 238.295% |
| Piramal Pharma Limited | 4.55 Billion INR | 184.551% |
| Sequent Scientific Limited | - INR | Infinity% |
| Sigachi Industries Limited | 1.47 Billion INR | 361.409% |
| Ajanta Pharma Limited | 19.67 Billion INR | 119.58% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 103.694% |
| Brooks Laboratories Limited | 14.44 Million INR | 26782.133% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 223.17% |
| Themis Medicare Limited | 392.58 Million INR | 1081.408% |
| Unichem Laboratories Limited | - INR | Infinity% |
| Hester Biosciences Limited | 364.81 Million INR | 1156.139% |
| Venus Remedies Limited | 534.65 Million INR | 820.638% |
| Indoco Remedies Limited | 1.29 Billion INR | 398.085% |
| Ind-Swift Limited | 1.22 Billion INR | 414.275% |
| Aarti Drugs Limited | 7.14 Billion INR | 153.896% |
| Alpa Laboratories Limited | 184.49 Million INR | 2188.327% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | 324.332% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 105.689% |
| Granules India Limited | 6.81 Billion INR | 156.521% |
| Gufic Biosciences Limited | 1.32 Billion INR | 389.711% |
| Hikal Limited | 32.11 Million INR | 12099.066% |
| RPG Life Sciences Limited | 2.29 Billion INR | 268.08% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 183.62% |
| Windlas Biotech Limited | 1.29 Billion INR | 396.63% |
| ZIM Laboratories Limited | 253.82 Million INR | 1617.912% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 187.159% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 341.289% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 174.251% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 109.129% |
| Bajaj HealthCare Limited | - INR | Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | 42585.693% |
| Ipca Laboratories Limited | 7.98 Billion INR | 148.278% |
| Lasa Supergenerics Limited | -458 Million INR | -741.235% |
| Laurus Labs Limited | 3.94 Billion INR | 197.576% |
| NATCO Pharma Limited | 25.96 Billion INR | 114.841% |
| Nectar Lifesciences Limited | 923.8 Million INR | 517.068% |
| Shilpa Medicare Limited | 1.36 Billion INR | 382.001% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 115.208% |
| Wanbury Limited | 569.71 Million INR | 776.284% |
| Wockhardt Limited | -670 Million INR | -475.06% |
| Strides Pharma Science Limited | 5.22 Billion INR | 173.728% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 412.989% |
| Suven Life Sciences Limited | -1.22 Billion INR | -214.312% |
| Amrutanjan Health Care Limited | 457.54 Million INR | 942.083% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 166.913% |
| Eris Lifesciences Limited | 5.18 Billion INR | 174.356% |
| Lupin Limited | 28.04 Billion INR | 113.739% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 6.37% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 1645.791% |
| Valiant Laboratories Limited | - INR | Infinity% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 108.938% |
| FDC Limited | 2.98 Billion INR | 229.023% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 126.976% |
| Novartis India Limited | 626.5 Million INR | 714.988% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | 858.251% |
| Neuland Laboratories Limited | 5.31 Billion INR | 172.449% |
| Morepen Laboratories Limited | 4.17 Billion INR | 192.311% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 1951.911% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 14131.976% |